semaglutide for bmi 25 patients with #obesity, semaglutide, a glucagon-like peptide-1 receptor agonist, is Higher-Dose Semaglutide Injection Proves Mettle

"Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques." Diabetes

This article explores the research on Mounjaro and fatigue, why it may happen, and practical steps a person can take to get their energy back

Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: a randomized, double-blind, placebo-controlled, multi-center clinical trial

Tirzepatide, sold under the brand names Mounjaro (type 2 diabetes) and Zepbound (chronic weight management and obstructive sleep apnea), is a dual GIP/GLP-1 agonist